Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2025 08:05 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical...
December 01, 2025 09:00 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors

PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in...
November 19, 2025 08:00 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award

PONTE VEDRA, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in...
November 10, 2025 09:00 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

PONTE VEDRA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in...
October 01, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global Left Ventricular Assist Devices Market Size/Share Worth USD 2.8 Billion by 2034 at a 8.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Left Ventricular Assist Devices Market Size, Trends and Insights By Product...
May 28, 2025 08:05 ET | Source: SeaStar Medical

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial Stands out as rare award with less than 100 clinical...
March 22, 2023 10:29 ET | Source: The Insight Partners

Cardiopulmonary Oxygenator Market: 4% CAGR, Portable ECMO Device Major Growth Driver from 2022-2028 | The Insight Partners

New York, March 22, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Cardiopulmonary Oxygenator Market Size, Share, Trends, Growth and Global Forecasts to 2028 -...
December 30, 2021 08:28 ET | Source: Research and Markets

Global Ventricular Assist Devices (VADs) Market, 2028 - Featuring Profiles of ABIOMED, Medtronic, Abbott, Berlin Heart, Cardiac Assist, and More

Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product, by Type Of Flow (Pulsatile Flow, Continuous Flow), by...
June 11, 2021 04:58 ET | Source: Research and Markets

Global Heart Pump Device Market (2021 to 2026) - Increasing Number of Product Approvals Presents Opportunities

Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Global Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type...
December 21, 2020 07:38 ET | Source: Research and Markets

Worldwide Ventricular Assist Device Industry to 2025 - North America Dominates the Market

Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Ventricular Assist Device Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...